drugset / Trial / NCT00474526
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
RandomizedParallel-groupOpen-labelPrevention
Summary
This study will evaluate the safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine when administered with routine infant vaccinations to healthy infants.
Timeline
- Start
- 2007-03
- Primary completion
- 2008-09
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ActHIB® (Haemophilus influenzae type b Conjugate Vaccine) | Vaccine | — | — |
| Subject | DTaP-IPV-HBV | Vaccine | — | — |
| Subject | Havrix® (Hepatitis A Vaccine, Inactivated) | Vaccine | — | — |
| Subject | Infanrix® (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) | Vaccine | — | — |
| Subject | Menveo | Vaccine | — | — |
| Subject | Prevnar 13 | Vaccine | — | — |
| Subject | ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine) | Vaccine | — | — |
| Subject | Rotavirus | Vaccine | — | Oral |